John D. Freedman, MD
Articles
April 19th 2013
Prescription Opioid Abuse: Challenges and Opportunities for Payers
Nathaniel P. Katz, MD, MS Howard Birnbaum, PhD Michael J. Brennan, MD John D. Freedman, MD Gary P. Gilmore, RPh Dennis Jay, BS George A. Kenna, PhD, RPh Bertha K. Madras, PhD Lisa McElhaney, BS Roger D. Weiss, MD Alan G. White, PhD
This article outlines strategies insurers can use to mitigate their risks related to prescription opioid abuse by members, while addressing this serious public health problem.
Latest Updated Articles
Published: October 21st 2024 | Updated: October 24th 2024
Lower Diagnostic Error Rates Found Among Hospitalized Patients During Care Transitions
Published: September 26th 2024 | Updated: October 1st 2024
Addressing Natural Disaster Takes Cooperation, Preparation to Ensure Patient Health
Published: May 9th 2024 | Updated: May 21st 2024
FDA Accepts Nivolumab Subcutaneous Injection Application, With Potential to Boost Access to PD-1 Inhibitors
Published: October 20th 2024 | Updated: November 5th 2024
FLT3 Inhibitor Gilteritinib May Also Be Effective as ALK Inhibitor in AML
Published: November 2nd 2024 | Updated: November 5th 2024
Patients With MDS Disagree With Physicians About Symptom Frequency
Published: February 2nd 2019 | Updated: November 5th 2024
Maternal Deaths, and Disparities, Become a Grassroots Cause
